The equity portion of the Fund rose (gross of fees) and outperformed its benchmark, the NASDAQ Biotechnology Index. Read more ...

Cytisinicline treatment for smoking cessation in adults will unlock about a $760 million market opportunity for the company, Morgan Stanley said in a Thursday note. The company plans to resubmit the ...

Wave Life Sciences has lost nearly 70% of its value this year, and its RNA platform could make it irresistible to the right ...

Electrification in life sciences is emerging as a strategic imperative beyond mere carbon reduction. New research reveals it significantly strengthens resilience, reduces operating costs, and enhances ...

Nominations are now open for the 2026 Fiercest Women in Life Sciences. | Who should be a 2026 Fiercest Woman in Life Sciences ...

Wave Life Sciences (WVE) stock analysis: low valuation (2.45x cash, no debt) vs. RNA therapy competition; key upside tied to WVE-N531 results. See more here.

Life sciences businesses are very healthy these days. Advances in research, testing, and manufacturing in the pharmaceutical, biotech, medical devices, and related industries continue to generate high ...

A ccording to the CBRE U.S. Life Sciences Outlook 2025 report, U.S life sciences employment hit a record high in 2024, and more job growth is expected in 2025. Meanwhile, the life sciences sector ...

Through this collaboration, users can analyze Carelon Real World Data (RWD) alongside third-party datasets without moving data outside their respective organizations, reducing risk and strengthening ...

With the life science park as the jewel in its crown, the life sciences zone in the Changping district of Beijing is growing and branching out into novel areas of research and development. In the post ...

Million in Cash and Cash Equivalents as of June 30, 2026 - NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS’’ or th ...